Literature DB >> 23945156

Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.

Atiqur Rahman1, Rasheduzzaman Rashu, Taufiqur Rahman Bhuiyan, Fahima Chowdhury, Ashraful Islam Khan, Kamrul Islam, Regina C LaRocque, Edward T Ryan, Jens Wrammert, Stephen B Calderwood, Firdausi Qadri, Jason B Harris.   

Abstract

Infection with Vibrio cholerae and oral cholera vaccines (OCVs) induce transient circulating plasmablast responses that peak within approximately 7 days after infection or vaccination. We previously demonstrated that plasmablast responses strongly correlate with subsequent levels of V. cholerae-specific duodenal antibodies up to 6 months after V. cholerae infection. Hence, plasmablast responses provide an early window into the immunologic memory at the mucosal surface. In this study, we characterized plasmablast responses following V. cholerae infection using a flow cytometrically defined population and compared V. cholerae-specific responses in adult patients with V. cholerae O1 infection and vaccinees who received the OCV Dukoral (Crucell Vaccines Canada). Among flow cytometrically sorted populations of gut-homing plasmablasts, almost 50% of the cells recognized either cholera toxin B subunit (CtxB) or V. cholerae O1 lipopolysaccharide (LPS). Using a traditional enzyme-linked immunosorbent spot assay (ELISPOT), we found that infection with V. cholerae O1 and OCVs induce similar responses to the protein antigen CtxB, but responses to LPS were diminished after OCV compared to those after natural V. cholerae infection. A second dose of OCV on day 14 failed to boost circulating V. cholerae-specific plasmablast responses in Bangladeshi adults. Our results differ from those in studies from areas where cholera is not endemic, in which a second vaccination on day 14 significantly boosts plasmablast responses. Given these results, it is likely that the optimal boosting strategies for OCVs differ significantly between areas where V. cholerae infection is endemic and those where it is not.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23945156      PMCID: PMC3807192          DOI: 10.1128/CVI.00347-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  24 in total

1.  Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children.

Authors:  F Qadri; C Wennerâs; F Ahmed; M Asaduzzaman; D Saha; M J Albert; R B Sack; A Svennerholm
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

2.  Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

Authors:  F Qadri; G Jonson; Y A Begum; C Wennerås; M J Albert; M A Salam; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Refractory periods and climate forcing in cholera dynamics.

Authors:  Katia Koelle; Xavier Rodó; Mercedes Pascual; Md Yunus; Golam Mostafa
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

4.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

5.  Enteric infections in an endemic area induce a circulating antibody-secreting cell response with homing potentials to both mucosal and systemic tissues.

Authors:  F Qadri; P H Mäkelä; J Holmgren; M J Albert; K Mannoor; A Kantele; D Saha; M A Salam; J M Kantele
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

6.  Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.

Authors:  Russell A Johnson; Taher Uddin; Amena Aktar; M Mohasin; Mohammad Murshid Alam; Fahima Chowdhury; Jason B Harris; Regina C LaRocque; Meagan Kelly Bufano; Yanan Yu; Ying Wu-Freeman; Daniel T Leung; David Sarracino; Bryan Krastins; Richelle C Charles; Peng Xu; Pavol Kovác; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

7.  Duration of infection-derived immunity to cholera.

Authors:  M M Levine; R E Black; M L Clements; L Cisneros; D R Nalin; C R Young
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

8.  Endemic cholera in rural Bangladesh, 1966-1980.

Authors:  R I Glass; S Becker; M I Huq; B J Stoll; M U Khan; M H Merson; J V Lee; R E Black
Journal:  Am J Epidemiol       Date:  1982-12       Impact factor: 4.897

9.  Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up.

Authors:  J D Clemens; D A Sack; J R Harris; F Van Loon; J Chakraborty; F Ahmed; M R Rao; M R Khan; M Yunus; N Huda
Journal:  Lancet       Date:  1990-02-03       Impact factor: 79.321

10.  The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa.

Authors:  Jacqueline L Deen; Lorenz von Seidlein; Dipika Sur; Magdarina Agtini; Marcelino E S Lucas; Anna Lena Lopez; Deok Ryun Kim; Mohammad Ali; John D Clemens
Journal:  PLoS Negl Trop Dis       Date:  2008-02-20
View more
  21 in total

1.  Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Ayan Dey; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

Review 2.  The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.

Authors:  Michael J Carter; Ruth M Mitchell; Patrick M Meyer Sauteur; Dominic F Kelly; Johannes Trück
Journal:  Front Immunol       Date:  2017-06-01       Impact factor: 7.561

3.  Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults.

Authors:  Rasheduzzaman Rashu; Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Lazina Hossain; Anik Paul; Ashraful Islam Khan; Fahima Chowdhury; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ana A Weil; Firdausi Qadri
Journal:  Microbes Infect       Date:  2018-12-21       Impact factor: 2.700

4.  Vaccine-induced plasmablast responses in rhesus macaques: phenotypic characterization and a source for generating antigen-specific monoclonal antibodies.

Authors:  Eduardo L V Silveira; Sudhir P Kasturi; Yevgeniy Kovalenkov; Ata Ur Rasheed; Patryce Yeiser; Zarpheen S Jinnah; Traci H Legere; Bali Pulendran; Francois Villinger; Jens Wrammert
Journal:  J Immunol Methods       Date:  2014-11-08       Impact factor: 2.303

5.  Spatial clustering of cholera cases in the Kathmandu Valley: implications for a ring vaccination strategy.

Authors:  Mellisa Roskosky; Mohammad Ali; Shyam Raj Upreti; David Sack
Journal:  Int Health       Date:  2021-02-24       Impact factor: 2.473

6.  Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Microbes Infect       Date:  2017-11-08       Impact factor: 2.700

7.  An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India.

Authors:  Suman Kanungo; Sachin N Desai; Jayanta Saha; Ranjan Kumar Nandy; Anuradha Sinha; Deok Ryun Kim; Barnali Bannerjee; Byomkesh Manna; Jae Seung Yang; Mohammad Ali; Dipika Sur; Thomas F Wierzba
Journal:  PLoS Negl Trop Dis       Date:  2015-05-29

8.  Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh.

Authors:  Brie Falkard; Taher Uddin; M Arifur Rahman; Molly F Franke; Amena Aktar; Muhammad Ikhtear Uddin; Taufiqur Rahman Bhuiyan; Daniel T Leung; Richelle C Charles; Regina C Larocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

Review 9.  Translating transitions - how to decipher peripheral human B cell development.

Authors:  Mats Bemark
Journal:  J Biomed Res       Date:  2015-04-28

10.  Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.

Authors:  Mohammad Ali; Amanda K Debes; Francisco J Luquero; Deok Ryun Kim; Je Yeon Park; Laura Digilio; Byomkesh Manna; Suman Kanungo; Shanta Dutta; Dipika Sur; Sujit K Bhattacharya; David A Sack
Journal:  PLoS Med       Date:  2016-09-13       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.